CSF3R and cyclic hematopoiesis: Taken together, our results support the following proposed mechanism for leukemia development in CN: CSF3R mutations represent a state of clonal hematopoiesis of indeterminate potential (CHIP) in CN patients in that they confer a clonal advantage.